(Press-News.org) CLEVELAND— More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS).
The drugs are effective but don’t eliminate the virus; HIV remains hidden in “reservoirs” throughout the body, ready to reactivate if treatment stops.
But researchers at Case Western Reserve University, in collaboration with the University of Pittsburgh, have made a significant breakthrough in HIV treatment. They’ve shown that NK (Natural Killer) cells—specialized immune cells that naturally target virus-infected and tumor cells—can be enhanced to better fight HIV infections.
Their findings were recently published in mBio, the scientific journal for the American Society of Microbiology.
“NK cell immunotherapy is already being used for cancer therapy, and the data from those studies provides a great foundation for translation of this approach to an HIV cure strategy,” said Mary Ann Checkley-Luttge, a senior research associate at the Case Western Reserve School of Medicine, who led the study. “We are hoping that NK cell immunotherapy can help reduce the reservoir enough to allow long-term immunological control of HIV without ART.”
Checkley-Luttge works in the lab of Jonathan Karn, a professor at the School of Medicine and pioneer in HIV research as director of the Case Center for AIDS Research.
The research team discovered that NK cells taken from HIV-positive patients can be expanded and enhanced in the lab to more effectively target and reduce these viral reservoirs.
This discovery marks a significant step toward long-term HIV remission by enhancing the body’s immune system. The approach could enable people with HIV to control the virus without lifelong dependence on daily antiretroviral medications.
The groundwork for such a discovery was supported by Case Western Reserve’s long-standing interdisciplinary collaboration and robust HIV research infrastructure. The School of Medicine houses a National Institutes of Health-designated Center for AIDS Research founded more than 30 years ago, and the Center for Excellence on the Impact of Substance Use on HIV, providing access to cutting-edge technologies essential for high-impact HIV research.
“Our team’s next goals are to test whether lab-enhanced NK cells can work as ‘off-the-shelf’ therapy,” said Karn, Distinguished University Professor and chair of the Department of Molecular Biology and Microbiology. “We plan to conduct studies using advanced animal models that closely mimic HIV infection in humans and then work toward clinical trials in the next two years to test this approach in people living with HIV.”
The research was made possible through blood donations from people living with HIV and represents a collaborative effort between patients, researchers and institutions working toward better HIV treatments.
###
About Case Western Reserve University
As one of the fastest-growing research universities in the United States, Case Western Reserve University is a force in career-defining education and life-changing research. Across our campus, more than 12,000 students from around the world converge to seek knowledge, find solutions and accelerate their impact. They learn from and collaborate with faculty members renowned for expertise in medicine, engineering, science, law, management, dental medicine, nursing, social work, and the arts. And with our location in Cleveland, Ohio—a hub of cultural, business and healthcare activity—our students gain unparalleled access to academic, research, clinical and entrepreneurial opportunities that prepare them to join our network of more than 125,000 alumni worldwide. Visit case.edu to see why Case Western Reserve University is built for those driven to be a force in the world.
END
LOS ANGELES — Parkinson’s disease is a progressive neurodegenerative disorder that affects more than one million people in the United States, with approximately 90,000 new cases diagnosed each year. Although available treatments can help manage symptoms, there is currently no cure or therapy proven to slow the progression of the disease.
Parkinson’s disease is associated with reduced dopamine release in the brain. Dopamine is a neurotransmitter essential for movement, memory, mood and ...
Alzheimer’s disease is often measured in statistics: millions affected worldwide, cases rising sharply, costs climbing into the trillions. For families, the disease is experienced far more intimately. “It’s a slow bereavement,” says Cold Spring Harbor Laboratory Professor Nicholas Tonks, whose mother lived with Alzheimer’s. “You lose the person piece by piece.”
There’s a lot of discussion about how the neurodegenerative disorder may be caused by a buildup of “plaque” ...
NLRP3 is a validated anti-inflammatory target that mediates the release of proinflammatory cytokines IL-1β and IL-18, and ISM5059 targets systemic inflammatory conditions by targeting NLRP3 and blocking the inflammatory cascade at its source.
Unlike ISM8969, Insilico’s brain-penetrant NLRP3 pipeline already with FDA IND clearance, ISM5059 features a completely different chemical core designed for peripheral-restricted potency.
Empowered by AI, ISM5059 demonstrated robust efficacy, excellent safety profiles in preclinical ...
Cardiovascular diseases constitute a major global health concern. Various complications that affect normal blood flow in arteries and veins, such as stroke, blood clot formation in veins, blood vessel rupture, and coronary artery disease, often require vascular treatments. However, existing vascular stent devices often require complex, invasive deployment procedures, making it necessary to explore novel materials and manufacturing technologies that could enable such medical devices to work more naturally with the human body. Moreover, the development of ...
Major depressive disorder (MDD) is a debilitating condition that affects more than 246 million people worldwide, yet scientists have struggled to identify consistent brain markers that could improve diagnosis and treatment. Finding reliable neurobiological markers for MDD has been hampered by the methodological differences observed across neuroimaging studies. Traditional brain imaging studies have produced conflicting results, often due to differences in methods and analysis pipelines. This inconsistency has made it difficult to pinpoint reliable neurobiological signatures of depression.
Against this backdrop, a new study led by Research Fellow Siti Nurul Zhahara ...
For Dementia Patients, Easy Access to Experts May Help the Most
Programs that match caregivers with patient navigators yield better outcomes than Alzheimer’sdrug – but combining the two may be best.
A Medicare-covered program that offers support and medical advice for caregivers of patients with dementia may bring more benefit than a costly Alzheimer’s medication, new research finds.
UC San Francisco researchers compared outcomes for patients in collaborative care programs with those taking lecanemab, one of two approved drugs that have been shown to slow progression of Alzheimer’s in some patients.
UCSF ...
YouTube is a great place to find all sorts of wildlife content. It is not, however, a good place to find viewers encouraging each other to preserve that wildlife, according to new research led by the University of Michigan.
Out of nearly 25,000 comments posted to more than 1,750 wildlife YouTube videos, just 2% featured a call to action that would help conservation efforts, according to a new study published in the journal Communications Sustainability.
"Our results basically show that people like to watch videos of zoos and safaris and ...
Researchers at UC San Francisco have uncovered a new clue to how Epstein-Barr virus (EBV) could contribute to multiple sclerosis (MS), a chronic autoimmune disease that affects nearly one million Americans.
The study, published Feb. 5 in Nature Immunology, found that certain types of CD8+ “killer” T cells — immune cells that destroy damaged or infected cells — are more abundant in people with MS. Some of these killer T cells target EBV, which suggests that the virus may trigger the damaging immune ...
Mass General Brigham investigators have developed a robust new artificial intelligence (AI) foundation model that is capable of analyzing brain MRI datasets to perform numerous medical tasks, including identifying brain age, predicting dementia risk, detecting brain tumor mutations and predicting brain cancer survival. The tool. known as BrainIAC, outperformed other, more task-specific AI models and was especially efficient when limited training data were available. Results are published in Nature Neuroscience.
“BrainIAC has ...
A new U of T Scarborough study finds that being mentally sharp can translate into a productivity boost equivalent to about 40 extra minutes of work each day.
The study, published in the journal Science Advances, followed participants over a 12-week period and found that day-to-day fluctuations in mental sharpness helped explain why people sometimes fail to follow through on their goals. On days when participants were mentally sharp, they were more likely to set goals and complete them, whether it was finishing assignments or even just cooking ...
